Literature DB >> 18520351

A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.

Daniela Bezemer1, Frank de Wolf, Maarten C Boerlijst, Ard van Sighem, T Deirdre Hollingsworth, Maria Prins, Ronald B Geskus, Luuk Gras, Roel A Coutinho, Christophe Fraser.   

Abstract

OBJECTIVE: Reducing viral load, highly active antiretroviral therapy has the potential to limit onwards transmission of HIV-1 and thus help contain epidemic spread. However, increases in risk behaviour and resurgent epidemics have been widely reported post-highly active antiretroviral therapy. The aim of this study was to quantify the impact that highly active antiretroviral therapy had on the epidemic.
DESIGN: We focus on the HIV-1 epidemic among men who have sex with men in the Netherlands, which has been well documented over the past 20 years within several long-standing national surveillance programs.
METHODS: We used a mathematical model including highly active antiretroviral therapy use and estimated the changes in risk behaviour and diagnosis rate needed to explain annual data on HIV and AIDS diagnoses.
RESULTS: We show that the reproduction number R(t), a measure of the state of the epidemic, declined early on from initial values above two and was maintained below one from 1985 to 2000. Since 1996, when highly active antiretroviral therapy became widely used, the risk behaviour rate has increased 66%, resulting in an increase of R(t) to 1.04 in the latest period 2000-2004 (95% confidence interval 0.98-1.09) near or just above the threshold for a self-sustaining epidemic. Hypothetical scenario analysis shows that the epidemiological benefits of highly active antiretroviral therapy and earlier diagnosis on incidence have been entirely offset by increases in the risk behaviour rate.
CONCLUSION: We provide the first detailed quantitative analysis of the HIV epidemic in a well defined population and find a resurgent epidemic in the era of highly active antiretroviral therapy, most likely predominantly caused by increasing sexual risk behaviour.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520351     DOI: 10.1097/QAD.0b013e3282fd167c

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  68 in total

1.  Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia.

Authors:  Frederik Graw; Thomas Leitner; Ruy M Ribeiro
Journal:  Epidemics       Date:  2012-05-02       Impact factor: 4.396

Review 2.  HIV treatment as prevention in men who have sex with men: examining the evidence.

Authors:  Patrick O'Byrne; Paul MacPherson
Journal:  CMAJ       Date:  2015-12-22       Impact factor: 8.262

3.  Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy.

Authors:  G Matusali; N Dereuddre-Bosquet; A Le Tortorec; M Moreau; A-P Satie; D Mahé; P Roumaud; O Bourry; N Sylla; S Bernard-Stoecklin; A Pruvost; R Le Grand; N Dejucq-Rainsford
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

Review 4.  Response to the AIDS pandemic--a global health model.

Authors:  Peter Piot; Thomas C Quinn
Journal:  N Engl J Med       Date:  2013-06-06       Impact factor: 91.245

5.  Genome-scale analysis of evolutionary rate and selection in a fast-expanding Spanish cluster of HIV-1 subtype F1.

Authors:  Juan Á Patiño-Galindo; Francisco Domínguez; María T Cuevas; Elena Delgado; Mónica Sánchez; Lucía Pérez-Álvarez; Michael M Thomson; Rafael Sanjuán; Fernando González-Candelas; José M Cuevas
Journal:  Infect Genet Evol       Date:  2018-09-13       Impact factor: 3.342

Review 6.  Mathematical models for the study of HIV spread and control amongst men who have sex with men.

Authors:  Narat Punyacharoensin; William John Edmunds; Daniela De Angelis; Richard Guy White
Journal:  Eur J Epidemiol       Date:  2011-09-20       Impact factor: 8.082

7.  Impact of early-stage HIV transmission on treatment as prevention.

Authors:  Kimberly A Powers; Mirjam E Kretzschmar; William C Miller; Myron S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

Review 8.  Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples.

Authors:  Rebecca F Baggaley; Richard G White; T Déirdre Hollingsworth; Marie-Claude Boily
Journal:  Epidemiology       Date:  2013-01       Impact factor: 4.822

9.  Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco.

Authors:  Moupali Das; Priscilla Lee Chu; Glenn-Milo Santos; Susan Scheer; Eric Vittinghoff; Willi McFarland; Grant N Colfax
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

Review 10.  HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention.

Authors:  Rebecca F Baggaley; Richard G White; Marie-Claude Boily
Journal:  Int J Epidemiol       Date:  2010-04-20       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.